| Style | Citing Format |
|---|---|
| MLA | Alahmari AD, et al.. "Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease in the Eastern Mediterranean." Hematology/ Oncology and Stem Cell Therapy, vol. 13, no. 2, 2020, pp. 106-110. |
| APA | Alahmari AD, Aljurf M, Alseraihy A, Hamidieh AA, Alkindi S, Rihani R, Satti T, Jastaniah W, Alsaedi H, Almohareb F, Aljefri A, Rasheed W (2020). Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease in the Eastern Mediterranean. Hematology/ Oncology and Stem Cell Therapy, 13(2), 106-110. |
| Chicago | Alahmari AD, Aljurf M, Alseraihy A, Hamidieh AA, Alkindi S, Rihani R, Satti T, et al.. "Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease in the Eastern Mediterranean." Hematology/ Oncology and Stem Cell Therapy 13, no. 2 (2020): 106-110. |
| Harvard | Alahmari AD et al. (2020) 'Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease in the Eastern Mediterranean', Hematology/ Oncology and Stem Cell Therapy, 13(2), pp. 106-110. |
| Vancouver | Alahmari AD, Aljurf M, Alseraihy A, Hamidieh AA, Alkindi S, Rihani R, et al.. Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease in the Eastern Mediterranean. Hematology/ Oncology and Stem Cell Therapy. 2020;13(2):106-110. |
| BibTex | @article{ author = {Alahmari AD and Aljurf M and Alseraihy A and Hamidieh AA and Alkindi S and Rihani R and Satti T and Jastaniah W and Alsaedi H and Almohareb F and Aljefri A and Rasheed W}, title = {Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease in the Eastern Mediterranean}, journal = {Hematology/ Oncology and Stem Cell Therapy}, volume = {13}, number = {2}, pages = {106-110}, year = {2020} } |
| RIS | TY - JOUR AU - Alahmari AD AU - Aljurf M AU - Alseraihy A AU - Hamidieh AA AU - Alkindi S AU - Rihani R AU - Satti T AU - Jastaniah W AU - Alsaedi H AU - Almohareb F AU - Aljefri A AU - Rasheed W TI - Hematopoietic Stem Cell Transplantation for Patients With Sickle Cell Disease in the Eastern Mediterranean JO - Hematology/ Oncology and Stem Cell Therapy VL - 13 IS - 2 SP - 106 EP - 110 PY - 2020 ER - |